Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
28 /100
MEDIUM RISK
Score updated Aug 28, 2026

APYX — Apyx Medical Corporation Dilution Risk Tracker

Track APYX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track APYX — Get alerts when the score changes →

As of August 28, 2026, Apyx Medical Corporation (APYX) has a DilutionWatch DilutionScore of 28/100, rated MEDIUM dilution risk. Apyx Medical Corporation has a market capitalization of $167.29M, 42.12M shares outstanding, 67 institutional holders tracked. Stored dilution-related fields include 1.25M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
10
📊 Float Risk
22
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for APYX.
🔔 Track APYX — Get forecast alerts →

Market Data

Market Cap$167.29M
Shares Outstanding42.12M
Float29.12M
Cash$27.62M
Debt$44.22M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 22.9% shares (2026Q1 vs prior)
67 institutional holders · 23.57M shares
#1 Nantahala Capital Management, LLC 3.44M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 3.11M shares
#3 Archon Capital Management LLC 2.79M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest267.1K
Days to Cover4.7
% of Float0.9%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2023-12-31
4 INSIDER TRANSACTION 2026-03-17
4 INSIDER TRANSACTION 2026-01-29
Full SEC filing analysis available with free account

Recent News

No recent news

Factual APYX Dilution Snapshot

Apyx Medical Corporation (APYX) has a DilutionScore of 28/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track APYX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking APYX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for APYX
APYX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.